You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information![](https://biocrates.com/wp-content/uploads/2024/02/Marissa.png)
Speaker | Marissa Jones, Ph.D.
Affiliation | biocrates life sciences ag | Business Development Manager
Metabolomics in pharma – Bridging R&D translation barriers
Part of the Webinar
Metabolomics in pharma – Bridging R&D translation barriers
In this lunch & learn event Marissa Jones shared insights on using metabolomics to uncover the “why” behind your research. Examine real-world case studies and see biocrates technology in action. Learn how metabolomics is making an impact in the pharmaceutical industry.
Related articles
- Oxaloacetic acid (OAA) – Key metabolite in metabolism, disease, and therapeutic innovation
- Introduction to metabolomics in action
- Investigating the stool and plasma metabolome of people with HIV
- Metabolomics of sepsis and critical illness
- Fast-tracking interpretation and sharing of lipidomic data with standardized methods